[
    [
        {
            "time": "",
            "original_text": "巨·研究| 全球医药外包产业链向国内转移 CRO/CMO企业迎机遇",
            "features": {
                "keywords": [
                    "全球医药外包",
                    "产业链转移",
                    "CRO",
                    "CMO",
                    "国内"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "巨·研究| 全球医药外包产业链向国内转移 CRO/CMO企业迎机遇",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "应对公共卫生紧急状态医药对策产品开发：FDA的实践与挑战",
            "features": {
                "keywords": [
                    "公共卫生",
                    "紧急状态",
                    "医药对策",
                    "FDA",
                    "实践",
                    "挑战"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "公共健康"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "应对公共卫生紧急状态医药对策产品开发：FDA的实践与挑战",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 4,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        }
    ]
]